Sectors
AstraZeneca looks to EU decision for next cancer drug boost
AstraZeneca's cancer drug pipeline, already on a roll following promising clinical trial results, could get a further boost next week from a European green light for an experimental medicine against ovarian cancer.
China military-linked firm eyes quick approval of drug to cure Ebola
A Chinese drugmaker with close military ties is seeking fast-track approval for a drug that it says can cure Ebola, as China joins the race to help treat a deadly outbreak of a disease that has spread from Africa to the United States and Europe.
French tourists avoid Tunisia after traveler's beheading in nearby Algeria
Tunisia lost about a third of its French tourist bookings to cancellation shortly after the beheading last month of a French traveler by Islamist militants in neighboring Algeria, the country's tourism minister said on Monday.
Facing new oil glut, Saudis avoid 1980s mistakes to halt price slide
Still haunted by its failed attempt to prevent a steep drop in oil prices by slashing production by almost three quarters in the 1980s, the world's top oil exporter Saudi Arabia is determined not to make the same mistake again.